Plasma NfL and GFAP as biomarkers of spinal cord degeneration in adrenoleukodystrophy.

Wouter J C van BallegoijStephanie I W van de StadtIrene C HuffnagelStephan KempEline A J WillemseCharlotte E TeunissenMarc Engelen

Published in: Annals of clinical and translational neurology (2020)

Our study illustrates the potential of plasma NfL as biomarker of spinal cord degeneration in adrenoleukodystrophy, which was superior to plasma GFAP in our cohort.

Keyphrases

spinal cord
spinal cord injury
neuropathic pain
risk assessment